Opinion
Published on 17 Sep 2013
Telaprevir or boceprevir for hepatitis C treatment: a first survey on pharmacoutilization
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00114
- 6,908 views
- 7 citations
